ctrl K

AI Score

Unlock

Monte Rosa Therapeutics I... (GLUE)

AI Score

Unlock

5.50

0.05 (0.92%)

At close: Feb 28, 2025, 3:59 PM

5.50

0.09%

After-hours: Feb 28, 2025, 04:00 PM EST

Monte Rosa Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	6.22M	8.56M	2.13M	537K	72K
Gross Profit	-6.22M	-8.56M	-2.13M	-537K	-72K
Operating Income	-143.31M	-112.38M	-72.88M	-28.01M	-7.99M
Interest Income	9.33M	3.76M	46K	9K	12.00
Pretax Income	-135.01M	-108.5M	-73.96M	-35.88M	-7.74M
Net Income	-135.35M	-104.62M	-71.94M	-36.07M	-8.02M
Selling & General & Admin	32.04M	27.32M	15.73M	4M	644K
Research & Development	105.05M	85.06M	57.16M	24M	7.35M
Other Expenses	n/a	n/a	-960K	-7.68M	276K
Operating Expenses	143.31M	112.38M	72.88M	28.01M	7.99M
Interest Expense	n/a	3.76M	n/a	n/a	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	143.31M	112.38M	72.88M	28.01M	7.99M
Income Tax	338K	-3.88M	-2.02M	189K	277K
Shares Outstanding (Basic)	51.4M	47.23M	46.54M	44M	44M
Shares Outstanding (Diluted)	51.4M	47.23M	46.54M	44M	44M
EPS (Basic)	-2.63	-2.22	-1.55	-0.82	-0.18
EPS (Diluted)	-2.63	-2.22	-1.55	-0.82	-0.18
EBITDA	-137.09M	-99.94M	-70.75M	-27.47M	-7.67M
Depreciation & Amortization	6.22M	8.56M	2.13M	537K	72K